04/24/2024
3:49 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/24/2024
3:23 PM | Nanobiotix (Filer)
| Form 20-F
Registration statement / Annual report / Transition report | |
04/17/2024
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/10/2024
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/09/2024
4:07 PM | Artal International S.C.A. (Filed by)
Nanobiotix (Subject)
| Form SC 13G/A | |
02/08/2024
7:27 PM | Nanobiotix (Subject)
Qatar Investment Authority (Filed by)
| Form SC 13G/A | |
|
02/02/2024
3:32 PM | JOHNSON & JOHNSON (Filed by)
JOHNSON & JOHNSON (Filed by)
Nanobiotix (Subject)
| Form SC 13G/A | |
01/29/2024
9:53 AM | BAILLIE GIFFORD & CO (Filed by)
Nanobiotix (Subject)
| Form SC 13G/A | |
12/26/2023
5:05 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/13/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023
3:32 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/09/2023
8:00 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2023
3:16 PM | Nanobiotix (Subject)
Qatar Investment Authority (Filed by)
| Form SC 13G | |
11/08/2023
6:53 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023
6:02 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/06/2023
3:12 PM | Nanobiotix (Filer)
| Form 424B5 | |
11/02/2023
3:36 PM | Nanobiotix (Subject)
| Form FWP | |
11/02/2023
9:56 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/23/2023
5:00 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2023
4:24 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/04/2023
3:43 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/29/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/28/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
3:33 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/05/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/19/2023
3:15 PM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/10/2023
5:05 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2023
7:19 AM | Nanobiotix (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/05/2023
5:00 AM | Nanobiotix (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
